Ticker Scorecard - VERV Basics Company: Verve Therapeutics, Inc. IPO Date: July 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $616.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 3.87% Avg Daily Range (30 D): $0.32 | 4.44% Avg Daily Range (90 D): $0.29 | 4.63% Institutional Daily Volume Avg Daily Volume: .83M Avg Daily Volume (30 D): 1.33M Avg Daily Volume (90 D): 1.26M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 91 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 1,326 Avg Inst. Trade: $2.08M Avg Inst. Trade (30 D): $1.38M Avg Inst. Trade (90 D): $1.49M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.52M Avg Closing Trade (30 D): $1.17M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 156.54K     News Feb 5, 2025 @ 7:33 PM France Programmatic Ad Seller Quality Rankings Q4 ... Source: Pixalate Jan 23, 2025 @ 8:47 PM Pixalate Releases Q4 2024 North America SSP Market... Source: Pixalate Jan 23, 2025 @ 8:40 PM Pixalate Releases Q4 2024 EMEA SSP Market Share Ra... Source: Pixalate Dec 12, 2024 @ 5:58 PM Pixalate Releases Q3 2024 EMEA Supply-Side Platfor... Source: Pixalate Dec 10, 2024 @ 8:19 PM Mexico Programmatic Ad Seller Quality Rankings Q3 ... Source: Pixalate Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.46 $-.59 $-.59 Diluted EPS $-2.46 $-.59 $-.59 Revenue $ 24.4M $ 6.87M $ 6.69M Gross Profit $ $ $ Net Income / Loss $ -197.03M $ -50.13M $ -49.81M Operating Income / Loss $ -226.54M $ -56.91M $ -58.84M Cost of Revenue $ $ $ Net Cash Flow $ 80.34M $ 17.22M $ -2.71M PE Ratio